Gilead Sciences (GILD) Total Debt (2016 - 2025)
Historic Total Debt for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $24.9 billion.
- Gilead Sciences' Total Debt rose 727.77% to $24.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $24.9 billion, marking a year-over-year increase of 727.77%. This contributed to the annual value of $26.7 billion for FY2024, which is 689.96% up from last year.
- As of Q3 2025, Gilead Sciences' Total Debt stood at $24.9 billion, which was up 727.77% from $24.9 billion recorded in Q2 2025.
- Gilead Sciences' Total Debt's 5-year high stood at $30.2 billion during Q2 2021, with a 5-year trough of $23.2 billion in Q3 2024.
- Over the past 5 years, Gilead Sciences' median Total Debt value was $25.2 billion (recorded in 2022), while the average stood at $25.9 billion.
- Data for Gilead Sciences' Total Debt shows a peak YoY increase of 2519.71% (in 2021) and a maximum YoY decrease of 1498.95% (in 2021) over the last 5 years.
- Quarter analysis of 5 years shows Gilead Sciences' Total Debt stood at $26.7 billion in 2021, then dropped by 5.49% to $25.2 billion in 2022, then fell by 0.96% to $25.0 billion in 2023, then rose by 6.9% to $26.7 billion in 2024, then fell by 6.63% to $24.9 billion in 2025.
- Its Total Debt stands at $24.9 billion for Q3 2025, versus $24.9 billion for Q2 2025 and $25.0 billion for Q1 2025.